DELUCIA DAVID (Chief Financial Officer) reported 2 transactions at KYNTRA BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/9/2025ACC: 0001415889-25-024014
Officer· Chief Financial Officer
Since Mar 2026
-104.00
Net shares
Net seller
$1.0K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
104.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−51.00
Price / share
$7.83
Trade value
$399.46
% of position
1.1%
6/6/2025
4.64K→4.59K
Common Stock
Direct
Shares
−53.00
Price / share
$12.10
Trade value
$641.30
% of position
1.2%
9/6/2025
4.59K→4.54K
Total
Net shares
−104.00
Net value
-$1.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/6/2025 | F · Tax Withholding | −51.00 | $7.83 | $399.46 | 1.1% | 4.64K | 4.59K |
| Common Stock Direct | 9/6/2025 | F · Tax Withholding | −53.00 | $12.10 | $641.30 | 1.2% | 4.59K | 4.54K |
| Total | −104.00 | -$1.04K | ||||||
Derivative Transactions0
No derivative transactions reported